U.S. Justice Department subpoenas Taro over generic drug pricing

WASHINGTON, Sept 11 (Reuters) - Taro Pharmaceutical Industries Ltd. and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed late on Friday.